ARCHIVES

NCI Criticized For Delays In Development Of New Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | January 24, 1975

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Grant Funding: The History Of a Controversy

July 23, 1993

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also

February 16, 1996

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

NIH Recovery Act Announcements

March 27, 2009